Skip to main content

Regeneron Pharmaceuticals Inc.

REGNHealthcare
CIK 0007134782SIC 3571Biotechnology
Market Cap

$287.4B

+2.4% today
Sector & Industry

Healthcare

Biotechnology

SEC Filings

896

Total filings on record

Last Filing

Feb 1, 2026

8-K — Board of Directors Update

Showing 15 filings
Form TypeFiled DateAcceptedDescriptionAccessionActions
13FFeb 1, 2026Feb 1, 2026Institutional Investment Manager Holdings Report0007134782-26-200146
DEF 14ADec 25, 2025Dec 25, 2025Definitive Proxy Statement for Annual Meeting0007134782-26-392606
S-1Nov 24, 2025Nov 24, 2025Registration Statement0007134782-26-932186
10-QOct 27, 2025Oct 27, 2025Quarterly Report for period ended December 20250007134782-26-922024
10-QOct 3, 2025Oct 3, 2025Quarterly Report for period ended June 20250007134782-26-104261
S-1Sep 10, 2025Sep 10, 2025Registration Statement0007134782-26-929699
8-KAug 10, 2025Aug 10, 2025Current Report - Material Event Disclosure0007134782-26-242118
Form 4Jul 19, 2025Jul 19, 2025Statement of Changes - James Brown0007134782-26-547274
Form 4Jun 17, 2025Jun 17, 2025Statement of Changes - James Brown0007134782-26-565900
S-1May 17, 2025May 17, 2025Registration Statement0007134782-26-942768
S-1Apr 22, 2025Apr 22, 2025Registration Statement0007134782-25-312138
10-KMar 17, 2025Mar 17, 2025Annual Report for fiscal year ended December 20250007134782-25-971249
10-QFeb 18, 2025Feb 18, 2025Quarterly Report for period ended March 20250007134782-25-379394
Form 4Jan 28, 2025Jan 28, 2025Statement of Changes - Michael Jones0007134782-25-811273
10-QJan 2, 2025Jan 2, 2025Quarterly Report for period ended March 20250007134782-25-101503